Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Analgesic effects of the non-nitrogen-containing bisphosphonates etidronate and clodronate, independent of anti-resorptive effects on bone.

Kim S, Seiryu M, Okada S, Kuroishi T, Takano-Yamamoto T, Sugawara S, Endo Y.

Eur J Pharmacol. 2013 Jan 15;699(1-3):14-22. doi: 10.1016/j.ejphar.2012.11.031. Epub 2012 Nov 28.

PMID:
23201069
2.

Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs.

Oizumi T, Funayama H, Yamaguchi K, Yokoyama M, Takahashi H, Yamamoto M, Kuroishi T, Kumamoto H, Sasaki K, Kawamura H, Sugawara S, Endo Y.

J Oral Maxillofac Surg. 2010 May;68(5):1043-54. doi: 10.1016/j.joms.2009.08.027. Epub 2010 Feb 13.

PMID:
20156665
3.

Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate.

Oizumi T, Yamaguchi K, Funayama H, Kuroishi T, Kawamura H, Sugawara S, Endo Y.

Basic Clin Pharmacol Toxicol. 2009 May;104(5):384-92. doi: 10.1111/j.1742-7843.2008.00374.x.

4.

Analgesic effect of bisphosphonates in mice.

Bonabello A, Galmozzi MR, Bruzzese T, Zara GP.

Pain. 2001 Apr;91(3):269-75.

PMID:
11275384
5.

Inhibition of phosphate transporters ameliorates the inflammatory and necrotic side effects of the nitrogen-containing bisphosphonate zoledronate in mice.

Okada S, Kiyama T, Sato E, Tanaka Y, Oizumi T, Kuroishi T, Takahashi T, Sasaki K, Sugawara S, Endo Y.

Tohoku J Exp Med. 2013;231(2):145-58.

6.

Inhibition of inflammatory and bone-resorption-inhibitory effects of alendronate by etidronate.

Funayama H, Ohsako M, Monma Y, Mayanagi H, Sugawara S, Endo Y.

Calcif Tissue Int. 2005 Jun;76(6):448-57. Epub 2005 May 19.

PMID:
15895282
7.

Bisphosphonates clodronate and etidronate in the prevention of ovariectomy-induced osteopenia in growing rats.

Lepola VT, Kippo K, Hannuniemi R, Laurén L, Virtamo T, Osterman T, Jalovaara P, Sellman R, Väänänen HK.

J Bone Miner Res. 1996 Oct;11(10):1508-17.

PMID:
8889851
8.

The Bisphosphonates Clodronate and Etidronate Exert Analgesic Effects by Acting on Glutamate- and/or ATP-Related Pain Transmission Pathways.

Shima K, Nemoto W, Tsuchiya M, Tan-No K, Takano-Yamamoto T, Sugawara S, Endo Y.

Biol Pharm Bull. 2016;39(5):770-7. doi: 10.1248/bpb.b15-00882.

9.

Comparative appraisal of clodronate, aspirin and dexamethasone as agents reducing alendronate-induced inflammation in a murine model.

Yu Z, Funayama H, Deng X, Kuroishi T, Sasano T, Sugawara S, Endo Y.

Basic Clin Pharmacol Toxicol. 2005 Oct;97(4):222-9.

10.

Inflammatory and necrotic effects of minodronate, a nitrogen-containing bisphosphonate, in mice.

Kiyama T, Okada S, Tanaka Y, Kim S, Bando K, Hasegawa M, Yamaguchi K, Takano-Yamamoto T, Sasaki K, Sugawara S, Endo Y.

Tohoku J Exp Med. 2013;230(3):141-9.

11.

Long-term analgesic effect of clodronate in rodents.

Bonabello A, Galmozzi MR, Canaparo R, Serpe L, Zara GP.

Bone. 2003 Oct;33(4):567-74.

PMID:
14555260
12.

In vitro cytotoxicity of zoledronate (nitrogen-containing bisphosphonate: NBP) and/or etidronate (non-NBP) in tumour cells and periodontal cells.

Tanaka Y, Nagai Y, Dohdoh M, Oizumi T, Ohki A, Kuroishi T, Sugawara S, Endo Y.

Arch Oral Biol. 2013 Jun;58(6):628-37. doi: 10.1016/j.archoralbio.2012.11.010. Epub 2012 Dec 12.

PMID:
23245859
13.

Bisphosphonates: preclinical aspects and use in osteoporosis.

Fleisch HA.

Ann Med. 1997 Feb;29(1):55-62. Review.

PMID:
9073324
14.

Comparison of the distribution of three bisphosphonates in mice.

Mönkkönen J, Koponen HM, Ylitalo P.

Pharmacol Toxicol. 1990 Apr;66(4):294-8.

PMID:
2142526
15.

Pro-IL-1β accumulation in macrophages by alendronate and its prevention by clodronate.

Shikama Y, Nagai Y, Okada S, Oizumi T, Shimauchi H, Sugawara S, Endo Y.

Toxicol Lett. 2010 Nov 30;199(2):123-8. doi: 10.1016/j.toxlet.2010.08.013. Epub 2010 Sep 8.

PMID:
20804833
16.

Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis.

Daubiné F, Le Gall C, Gasser J, Green J, Clézardin P.

J Natl Cancer Inst. 2007 Feb 21;99(4):322-30.

17.
19.

Treatment effects of bisphosphonates on ovariectomy-induced osteopenia in rats: comparison between clodronate and etidronate.

Itoh F, Shiraki M, Komatsu H, Imai Y, Komatsu Y, Taya F, Kojima M.

J Bone Miner Metab. 1999;17(4):252-8.

PMID:
10575589
20.

Short-term intravenous bisphosphonates in prevention of postmenopausal bone loss.

Heikkinen JE, Selander KS, Laitinen K, Arnala I, Väänänen HK.

J Bone Miner Res. 1997 Jan;12(1):103-10.

Items per page

Supplemental Content

Write to the Help Desk